en
Scientific article
English

Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry

Published inJoint bone spine, vol. 80, no. 2, p. 160-164
Publication date2013
Abstract

In Switzerland, the prescription of biologic antirheumatic agents in rheumatoid arthritis (RA) patients is not limited by stringent requirements from health authorities. The goals of this study were to: determine the characteristics of the Swiss patients at the initiation of biologics, compare them with other countries and evaluate whether different disease activity levels at initiation of therapy, resulting from distinct access to these treatment, influence their effectiveness.

Keywords
  • Adult
  • Aged
  • Antirheumatic Agents/therapeutic use
  • Arthritis, Rheumatoid/drug therapy/epidemiology/physiopathology
  • Biological Therapy
  • Cross-Cultural Comparison
  • Europe/epidemiology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Registries/statistics & numerical data
  • Retrospective Studies
  • Switzerland/epidemiology
  • Treatment Outcome
Citation (ISO format)
ZUFFEREY, Pascal et al. Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry. In: Joint bone spine, 2013, vol. 80, n° 2, p. 160–164. doi: 10.1016/j.jbspin.2012.05.003
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1297-319X
475views
0downloads

Technical informations

Creation07/31/2014 3:22:00 PM
First validation07/31/2014 3:22:00 PM
Update time03/14/2023 10:46:28 PM
Status update03/14/2023 10:46:28 PM
Last indexation08/29/2023 2:32:56 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack